About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tsc1tm1.1Djk
targeted mutation 1.1, David J Kwiatkowski
MGI:2183900
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Tsc1tm1.1Djk/Tsc1tm1.1Djk either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J) MGI:3588772
ht2
Tsc1tm1.1Djk/Tsc1+ either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J) MGI:3588773
cn3
Tsc1tm1Djk/Tsc1tm1.1Djk
Tg(Syn1-cre)671Jxm/0
involves: 129S4/SvJae * C57BL/6 * CBA MGI:3802545
cx4
Lin28atm1.1Gqda/Lin28atm1.1Gqda
Tsc1tm1.1Djk/Tsc1+
involves: 129S4/SvJae * C57BL/6 MGI:5519079
cx5
Lin28btm1.1Gqda/Lin28btm1.1Gqda
Tsc1tm1.1Djk/Tsc1+
involves: 129S4/SvJae * C57BL/6 * FVB MGI:5519080


Genotype
MGI:3588772
hm1
Allelic
Composition
Tsc1tm1.1Djk/Tsc1tm1.1Djk
Genetic
Background
either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tsc1tm1.1Djk mutation (1 available); any Tsc1 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• viability of embryos steadily declined from E9 to E13.5
• no viable null embryos were observed beyond E13.5

embryo
• typically by approximately one embryonic day less developed

liver/biliary system
• hypoplastic liver with poorly developed other abdominal organs
• the liver and other abdominal organs had dilated vascular channels

homeostasis/metabolism
• viable E9-12.5 embryo often had pericardial effusions
• viable E9-12.5 embryos are edematous

cardiovascular system
• sightly enlarged heart that was shifted inferiorly
• viable E9-12.5 embryo often had pericardial effusions

growth/size/body
• sightly enlarged heart that was shifted inferiorly
• typically by approximately one embryonic day less developed

integument
• viable E9-12.5 embryos are paler




Genotype
MGI:3588773
ht2
Allelic
Composition
Tsc1tm1.1Djk/Tsc1+
Genetic
Background
either: 129S4/SvJae-Tsc1tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tsc1tm1.1Djk mutation (1 available); any Tsc1 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• increased premature death before 18 month of age for female and in a co-isogenic 129SvJae background, due to increased incidence of severe liver hemangioma leading to spontaneous bleeding

neoplasm
• consisting of aberrant vascular channels of highly variable size that often had cuboidal-columnar endothelial cells, and proliferation of smooth muscle cells
• these lesions were seen in 67% males and 93% females
• these lesions are more severe in female compared to male, causing more death in female
• multiple bilateral renal cystadenomas in all heterozygous mice by 15-18 months of age
• varied from pure cysts with cuboidal lining cells to cysts with papillary projections, to a solid adenomas
• Background Sensitivity: there were more cystadenomas in BALB/cJ hybrid background, but no sex difference were seen
• 6 out of 31 heterozygous mice showed histologic features consistent with progression to renal cell carcinoma
• no evidence of metastasis was found in those mice
• 1out of 31 heterozygous mice showed hemangiosarcoma of the forepaw

renal/urinary system
• multiple bilateral renal cystadenomas in all heterozygous mice by 15-18 months of age
• varied from pure cysts with cuboidal lining cells to cysts with papillary projections, to a solid adenomas
• Background Sensitivity: there were more cystadenomas in BALB/cJ hybrid background, but no sex difference were seen
• 6 out of 31 heterozygous mice showed histologic features consistent with progression to renal cell carcinoma
• no evidence of metastasis was found in those mice

liver/biliary system
• consisting of aberrant vascular channels of highly variable size that often had cuboidal-columnar endothelial cells, and proliferation of smooth muscle cells
• these lesions were seen in 67% males and 93% females
• these lesions are more severe in female compared to male, causing more death in female

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
tuberous sclerosis DOID:13515 OMIM:PS191100
J:75243




Genotype
MGI:3802545
cn3
Allelic
Composition
Tsc1tm1Djk/Tsc1tm1.1Djk
Tg(Syn1-cre)671Jxm/0
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Syn1-cre)671Jxm mutation (1 available)
Tsc1tm1.1Djk mutation (1 available); any Tsc1 mutation (71 available)
Tsc1tm1Djk mutation (2 available); any Tsc1 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• median survival of 35 days, with no survivors beyond 65 days (J:121858)
• mice treated with rapamycin or RAD001 (mTOR inhibitor) show 90-100% survival to 80 days of age compared to median survival of 33 days for untreated mutants (J:136366)
• discontinuation of drug treatment at P30 results in clinical symptom improvement for 1-2 weeks followed by clinical deterioration and death at 79 days for rapamycin-treated and 77 days for RAD001-treated mutants (J:136366)

growth/size/body
• after P5 until death, mutants fail to gain weight at same rate as controls; average maximum weight is 10 grams

nervous system
• mice develop clinical seizures, spontaneous and some provoked in most part by physical simulation; both types of seizures are mild or severe
• severe seizures are characterized by brief behavioral arrest, followed by several seconds of clonic activity, followed by tonic extensor posturing of trunk and limbs for 15-45 seconds
• after P21, suspension by the tail results in gentle spinning leading severe seizure activity, followed by bradycardia and death
• only mild seizures occur spontaneously, characterized by brief myoclonic jerking of head and torso
• enlarged cells are seen outside cerebral cortex, in other parts of brain including thalamus, hypothalamus and brainstem
• no increased cell loss or degeneration is observed in regions containing anomalous enlarged cells
• brain weight to body weight ratio is significantly greater (2.4-fold) in mutants compared to wild-type; with rapamycin/RAD001 treatment, difference from control is significantly reduced but still observed
• enlarged cells are observed in hilus
• enlarged cells are seen throughout pyramidal cell layer, particularly in CA3 region
• enlarged ectopic cells are seen outside the CA1-CA3 fields in stratum oriens and stratum radiatum
• laminar organization is less distinct than in the 6 cortical layers of controls (J:121858)
• unusually large cells are observed in all six layers in mutants, particularly in layer V; layer of enlarged cells is seen at gray-white matter border throughout cerebral cortex at P21 (J:121858)
• mutants display subset of enlarged pS6-positive cells at base of cortex and in cortical layer V; drug treatment results in marked reduction in size of enlarged cells (J:136366)
• mild cortical disorganization is observed in mutants with or without rapamycin treatment (J:136366)
• contains some enlarged cells
• Nissl bodies and filamentous aggregates are often detected in enlarged neurons, prominently in brainstem but rarely in enlarged cortical cells (J:121858)
• some neurons are aberrantly localized outside primary pyramidal cell layers; ectopic neurons are isolated, not organized into clusters or columns (J:121858)
• some neurons in somatosensory cortex show 60% increase in soma size relative to controls (J:121858)
• many pyramidal neurons demonstrate dysplastic features including increased size and thicker dendritic arbors compared to control neurons (J:121858)
• population of neurons in lateral somatosensory cortex are considerably enlarged compared with those in controls; size is significantly reduced after drug treatment (from 1.8-fold to 1.2-fold), but effect reverses when treatment is stopped (J:136366)
• in somatosensory cortex, layer V neurons often have major dendrites extending tangentially and diagonally to the pia, in contrast to control neurons which mainly have long apical dendrite oriented directly toward pial surface; rapamycin treatment initiated at P7 does not significantly decrease abnormally oriented dendrite percentage (J:136366)
• in mutant brains, neurons appear to be still actively growing after P14-21, whereas wild-type neurons have stopped growing
• this may result in the hypomyelination, due to secondary myelination failure
• in hippocampal neuron cultures, neuronal dendritic spine density is reduced >20% compared to controls
• with rapamycin treatment, spine density is marginally increased; spine length however is increased 9% compared to treated and untreated controls or untreated mutants
• hypomyelination is observed in brains of mutants (J:121858)
• oligodendrocyte number and distribution appears similar to wild-type (J:121858)
• myelination particularly in cortex is impaired due to decreased myelin production by oligodendrocytes; rapamycin treatment works to restore myelination throughout brain with greatest improvement in cortex and hippocampus (J:136366)
• mice aged P21-48 display 3 types of electrographic abnormalities: short spike bursts observed in all mice examined, occasionally spontaneous period of desynchronization with electrodecrement and at low incidence, frequent high-amplitude sharp waves
• interictal (seizure) 1-2 second bursts of high-amplitude 7-8 hertz spikes are observed with high frequency compared with controls; these are without obvious clinical correlate

behavior/neurological
• clasping behavior and tremor are significantly ameliorated by rapamycin/RAD001 treatment relative to untreated animals at 30, 60, and 100 days postnatal
• apparent by P10
• display posterior limb-clasping behavior when lifted by tail
• progressive high-frequency trunk and limb tremor apparent by P10
• at death, usually in third to fifth postnatal week, mice are found with extensor posture of fore- and hindlimbs
• develops by by third or fourth postnatal week
• tail dorsiflexion is exhibited
• mice show progressive decline in activity with limited mobility by third or fourth postnatal week
• apparent by P10
• mice develop clinical seizures, spontaneous and some provoked in most part by physical simulation; both types of seizures are mild or severe
• severe seizures are characterized by brief behavioral arrest, followed by several seconds of clonic activity, followed by tonic extensor posturing of trunk and limbs for 15-45 seconds
• after P21, suspension by the tail results in gentle spinning leading severe seizure activity, followed by bradycardia and death
• only mild seizures occur spontaneously, characterized by brief myoclonic jerking of head and torso

skeleton
• kyphosis is significantly improved in rapamycin/RAD001-treated mice compared with untreated mutants

cellular
• in mutant brains, neurons appear to be still actively growing after P14-21, whereas wild-type neurons have stopped growing
• this may result in the hypomyelination, due to secondary myelination failure

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
tuberous sclerosis DOID:13515 OMIM:PS191100
J:136366




Genotype
MGI:5519079
cx4
Allelic
Composition
Lin28atm1.1Gqda/Lin28atm1.1Gqda
Tsc1tm1.1Djk/Tsc1+
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lin28atm1.1Gqda mutation (1 available); any Lin28a mutation (76 available)
Tsc1tm1.1Djk mutation (1 available); any Tsc1 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• as in Lin28atm1.1Gqda homozygotes

growth/size/body
• dwarfism as in Lin28atm1.1Gqda homozygotes




Genotype
MGI:5519080
cx5
Allelic
Composition
Lin28btm1.1Gqda/Lin28btm1.1Gqda
Tsc1tm1.1Djk/Tsc1+
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lin28btm1.1Gqda mutation (1 available); any Lin28b mutation (23 available)
Tsc1tm1.1Djk mutation (1 available); any Tsc1 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
N
• male mice exhibit normal growth





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/05/2024
MGI 6.24
The Jackson Laboratory